195 related articles for article (PubMed ID: 29962397)
1. Physiological Roles of Metallothioneins in Central Nervous System Diseases.
Nakamura S; Shimazawa M; Hara H
Biol Pharm Bull; 2018; 41(7):1006-1013. PubMed ID: 29962397
[TBL] [Abstract][Full Text] [Related]
2. Roles of the metallothionein family of proteins in the central nervous system.
Hidalgo J; Aschner M; Zatta P; Vasák M
Brain Res Bull; 2001 May; 55(2):133-45. PubMed ID: 11470309
[TBL] [Abstract][Full Text] [Related]
3. An insight into the complex roles of metallothioneins in malignant diseases with emphasis on (sub)isoforms/isoforms and epigenetics phenomena.
Krizkova S; Kepinska M; Emri G; Eckschlager T; Stiborova M; Pokorna P; Heger Z; Adam V
Pharmacol Ther; 2018 Mar; 183():90-117. PubMed ID: 28987322
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein (MT) isoforms in the central nervous system (CNS): regional and cell-specific distribution and potential functions as an antioxidant.
Aschner M
Neurotoxicology; 1998; 19(4-5):653-60. PubMed ID: 9745925
[TBL] [Abstract][Full Text] [Related]
5. Metallothioneins I and II: neuroprotective significance during CNS pathology.
Stankovic RK; Chung RS; Penkowa M
Int J Biochem Cell Biol; 2007; 39(3):484-9. PubMed ID: 17097331
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein polymorphisms in pathological processes.
Raudenska M; Gumulec J; Podlaha O; Sztalmachova M; Babula P; Eckschlager T; Adam V; Kizek R; Masarik M
Metallomics; 2014 Jan; 6(1):55-68. PubMed ID: 24068159
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein in Brain Disorders.
Juárez-Rebollar D; Rios C; Nava-Ruíz C; Méndez-Armenta M
Oxid Med Cell Longev; 2017; 2017():5828056. PubMed ID: 29085556
[TBL] [Abstract][Full Text] [Related]
8. The expression of metallothioneins is diminished in the spinal cords of patients with sporadic ALS.
Hozumi I; Yamada M; Uchida Y; Ozawa K; Takahashi H; Inuzuka T
Amyotroph Lateral Scler; 2008 Oct; 9(5):294-8. PubMed ID: 18608104
[TBL] [Abstract][Full Text] [Related]
9. Metallothioneins in Normal and Cancer Cells.
Dziegiel P; Pula B; Kobierzycki C; Stasiolek M; Podhorska-Okolow M
Adv Anat Embryol Cell Biol; 2016; 218():1-117. PubMed ID: 26847563
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein isoforms as double agents - Their roles in carcinogenesis, cancer progression and chemoresistance.
Merlos Rodrigo MA; Jimenez Jimemez AM; Haddad Y; Bodoor K; Adam P; Krizkova S; Heger Z; Adam V
Drug Resist Updat; 2020 Sep; 52():100691. PubMed ID: 32615524
[TBL] [Abstract][Full Text] [Related]
11. Metallothioneins and the central nervous system: from a deregulation in neurodegenerative diseases to the development of new therapeutic approaches.
Bolognin S; Cozzi B; Zambenedetti P; Zatta P
J Alzheimers Dis; 2014; 41(1):29-42. PubMed ID: 24577478
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of metallothioneins in human diseases--A review.
Krizkova S; Kepinska M; Emri G; Rodrigo MA; Tmejova K; Nerudova D; Kizek R; Adam V
J Pharm Biomed Anal; 2016 Jan; 117():464-73. PubMed ID: 26454339
[TBL] [Abstract][Full Text] [Related]
13. Advances in metallothionein structure and functions.
Vasák M
J Trace Elem Med Biol; 2005; 19(1):13-7. PubMed ID: 16240666
[TBL] [Abstract][Full Text] [Related]
14. The potential roles of metallothionein as a therapeutic target for cerebral ischemia and retinal diseases.
Ito Y; Tanaka H; Hara H
Curr Pharm Biotechnol; 2013; 14(4):400-7. PubMed ID: 23590137
[TBL] [Abstract][Full Text] [Related]
15. Metallothioneins (MTs) in the human eye: a perspective article on the zinc-MT redox cycle.
Gonzalez-Iglesias H; Alvarez L; García M; Petrash C; Sanz-Medel A; Coca-Prados M
Metallomics; 2014 Feb; 6(2):201-8. PubMed ID: 24419560
[TBL] [Abstract][Full Text] [Related]
16. Basal and copper-induced expression of metallothionein isoform 1,2 and 3 genes in epithelial cancer cells: The role of tumor suppressor p53.
Ostrakhovitch EA; Song YP; Cherian MG
J Trace Elem Med Biol; 2016 May; 35():18-29. PubMed ID: 27049123
[TBL] [Abstract][Full Text] [Related]
17. Sunflower metallothionein family characterisation. Study of the Zn(II)- and Cd(II)-binding abilities of the HaMT1 and HaMT2 isoforms.
Tomas M; Pagani MA; Andreo CS; Capdevila M; Atrian S; Bofill R
J Inorg Biochem; 2015 Jul; 148():35-48. PubMed ID: 25770010
[TBL] [Abstract][Full Text] [Related]
18. The antiviral role of zinc and metallothioneins in hepatitis C infection.
Read SA; Parnell G; Booth D; Douglas MW; George J; Ahlenstiel G
J Viral Hepat; 2018 May; 25(5):491-501. PubMed ID: 29239069
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein functions and structural characteristics.
Carpenè E; Andreani G; Isani G
J Trace Elem Med Biol; 2007; 21 Suppl 1():35-9. PubMed ID: 18039494
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein-protein interactions.
Atrian S; Capdevila M
Biomol Concepts; 2013 Apr; 4(2):143-60. PubMed ID: 25436572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
